BAILLIE GIFFORD & CO 13D and 13G filings for AbCellera Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-09 10:20 am Sale |
2024-09-30 | 13G | AbCellera Biologics Inc. ABCL |
BAILLIE GIFFORD & CO | 12,894,703 4.400% |
-11,150,093 (-46.37%) |
Filing |
| 2024-01-29 11:47 am Purchase |
2023-12-29 | 13G | AbCellera Biologics Inc. ABCL |
BAILLIE GIFFORD & CO | 24,044,796 8.290% |
4,348,061 (+22.08%) |
Filing |
| 2023-01-18 06:35 am Purchase |
2022-12-30 | 13G | AbCellera Biologics Inc. ABCL |
BAILLIE GIFFORD & CO | 19,696,735 6.880% |
19,696,735 (New Position) |
Filing |